Evidence map›Paper›PMID 10318832›Full record

ArticleThe Journal of biological chemistry1999

cAMP-dependent mobilization of intracellular Ca2+ stores by activation of ryanodine receptors in pancreatic beta-cells. A Ca2+ signaling system stimulated by the insulinotropic hormone glucagon-like peptide-1-(7-37).

G G Holz, C A Leech, R S Heller, M Castonguay, J F Habener

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 90 papers.

0numbers the graph read from it
0cells of the map it votes in
90citing papers in PubMed
12.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

90 citing papers in PubMed, 224 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Review
  5. Article
  6. Purinergic agonists increase [CaAmerican journal of physiology. Cell physiology · 2024
    Article
  7. Review
  8. Metabolic and Molecular Amplification of Insulin Secretion.Advances in anatomy, embryology, and cell biology · 2024
    Review
  9. Article
  10. Mechanisms of action of incretin receptor based dual- and tri-agonists in pancreatic islets.American journal of physiology. Endocrinology and metabolism · 2023
    Review
  11. High-resolution analysis of the cytosolic CaAmerican journal of physiology. Endocrinology and metabolism · 2023
    Article
  12. Liraglutide increases islet CaDiabetes, obesity & metabolism · 2022
    Article
  13. Article
  14. Review
  15. The Pancreatic β-Cell: The Perfect Redox System.Antioxidants (Basel, Switzerland) · 2021
    Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Glucagon-like peptide 1 (GLP-1).Molecular metabolism · 2019 · on this map
    Review

30 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

G G HolzDiabetes Unit, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114, USA. holz@helix.mgh.harvard.edu
C A Leech
R S Heller
M Castonguay
J F Habener
Harvard University · USMassachusetts General Hospital · US

Funding

Insulinotropin: A Modulator Of B-Cell Glucose SignalingR01DK045817 · NIDDK · UPSTATE MEDICAL UNIVERSITY · PI HOLZ, GEORGE G · 2001 to 2008
$3.0M
GLUCAGON BIOSYNTHESIS &METABOLISMR01DK030834 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI HABENER, JOEL F · 1986 to 2008
$1.9M
MOLECULAR BASIS OF ANTIDIABETOGENIC HORMONE ACTIONR01DK052166 · NIDDK · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI HOLZ, GEORGE G · 1997 to 2000
$205k
INSULINOTROPIN: A MODULATOR OF B-CELL GLUCOSE SIGNALLINGR29DK045817 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI HOLZ, GEORGE G · 1993 to 1997
–
NIDDK NIH HHS DK-30834NIDDK NIH HHS DK-45817NIDDK NIH HHS DK-52166NIDDK NIH HHS R01 DK030834NIDDK NIH HHS R01 DK045817
6 · The paper itself

Abstract

Glucagon-like peptide-1 (GLP-1) is an intestinally derived insulinotropic hormone currently under investigation for use as a novel therapeutic agent in the treatment of type 2 diabetes mellitus. In vitro studies of pancreatic islets of Langerhans demonstrated that GLP-1 interacts with specific beta-cell G protein-coupled receptors, thereby facilitating insulin exocytosis by raising intracellular levels of cAMP and Ca2+. Here we report that the stimulatory influence of GLP-1 on Ca2+ signaling results, in part, from cAMP-dependent mobilization of ryanodine-sensitive Ca2+ stores. Studies of human, rat, and mouse beta-cells demonstrate that the binding of a fluorescent derivative of ryanodine (BODIPY FL-X ryanodine) to its receptors is specific, reversible, and of high affinity. Rat islets and BTC3 insulinoma cells are shown by reverse transcriptase polymerase chain reaction analyses to express mRNA corresponding to the type 2 isoform of ryanodine receptor-intracellular Ca2+ release channel (RYR2). Single-cell measurements of [Ca2+]i using primary cultures of rat and human beta-cells indicate that GLP-1 facilitates Ca2+-induced Ca2+ release (CICR), whereby mobilization of Ca2+ stores is triggered by influx of Ca2+ through L-type Ca2+ channels. In these cells, GLP-1 is shown to interact with metabolism of D-glucose to produce a fast transient increase of [Ca2+]i. This effect is reproduced by 8-Br-cAMP, but is blocked by a GLP-1 receptor antagonist (exendin-(9-39)), a cAMP antagonist ((Rp)-cAMPS), an L-type Ca2+ channel antagonist (nimodipine), an antagonist of the sarco(endo)plasmic reticulum Ca2+ ATPase (thapsigargin), or by ryanodine. Characterization of the CICR mechanism by voltage clamp analysis also demonstrates a stimulation of Ca2+ release by caffeine. These findings provide new support for a model of beta-cell signal transduction whereby GLP-1 promotes CICR by sensitizing intracellular Ca2+ release channels to the stimulatory influence of cytosolic Ca2+.

Indexed as

Signal TransductionAnimalsBoron CompoundsCaffeineCalciumCyclic AMPFluorescent DyesGlucagonGlucagon-Like Peptide 1HumansIslets of LangerhansMiceMice, Inbred C57BLPeptide FragmentsPolymerase Chain ReactionProtein Precursors4,4-difluoro-4-bora-3a,4a-diaza-s-indaceneBoron CompoundsCaffeineCalciumCyclic AMPFluorescent DyesGlucagonGlucagon-Like Peptide 1Peptide FragmentsProtein PrecursorsRNA, MessengerRyanodineRyanodine Receptor Calcium Release Channel

Identifiers

PMID10318832
PMCPMC3508791
OpenAlexW2016242736

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.